Recce Pharmaceuticals Ltd.ASX: RCE

Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort

May 15, 2024 at 6:07 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment